2022 Q1 Form 10-K Financial Statement
#000095017022004418 Filed on March 23, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 |
---|---|---|---|
Revenue | $9.033M | $9.891M | $33.20M |
YoY Change | 21.62% | -57.64% | 42.17% |
Cost Of Revenue | $6.754M | $7.439M | $24.86M |
YoY Change | 18.8% | -61.78% | 27.71% |
Gross Profit | $2.279M | $2.452M | $8.336M |
YoY Change | 30.83% | -36.89% | 114.57% |
Gross Profit Margin | 25.23% | 24.79% | 25.11% |
Selling, General & Admin | $11.99M | $11.31M | $33.91M |
YoY Change | 83.71% | -57.62% | 27.04% |
% of Gross Profit | 525.89% | 461.38% | 406.83% |
Research & Development | $4.850M | $4.258M | $18.57M |
YoY Change | -3.88% | -79.19% | -9.25% |
% of Gross Profit | 212.81% | 173.65% | 222.74% |
Depreciation & Amortization | $246.0K | $483.0K | $1.426M |
YoY Change | -39.11% | -71.64% | -31.41% |
% of Gross Profit | 10.79% | 19.7% | 17.11% |
Operating Expenses | $16.84M | $16.02M | $52.74M |
YoY Change | 45.33% | -65.68% | 12.98% |
Operating Profit | -$14.56M | -$13.57M | -$44.41M |
YoY Change | 47.9% | -68.3% | 3.76% |
Interest Expense | -$966.0K | -$388.0K | -$4.162M |
YoY Change | -90.79% | -1.16% | |
% of Operating Profit | |||
Other Income/Expense, Net | $247.0K | $71.00K | |
YoY Change | -28.61% | -79.48% | |
Pretax Income | -$15.52M | -$13.71M | -$48.50M |
YoY Change | 42.33% | -70.62% | 3.93% |
Income Tax | $0.00 | $2.000K | $2.000K |
% Of Pretax Income | |||
Net Earnings | -$15.52M | -$13.71M | -$48.50M |
YoY Change | 42.33% | -70.62% | 3.93% |
Net Earnings / Revenue | -171.84% | -138.62% | -146.09% |
Basic Earnings Per Share | -$0.59 | -$8.52 | |
Diluted Earnings Per Share | -$587.8K | -$520.0K | -$1.842M |
COMMON SHARES | |||
Basic Shares Outstanding | 26.40M | 26.33M | 5.695M |
Diluted Shares Outstanding | 26.41M | 5.695M |
Balance Sheet
Concept | 2022 Q1 | 2021 Q4 | 2021 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $66.05M | $84.64M | $84.64M |
YoY Change | 63.65% | ||
Cash & Equivalents | $66.10M | $84.64M | $84.64M |
Short-Term Investments | |||
Other Short-Term Assets | $3.968M | $3.552M | $3.552M |
YoY Change | 294.23% | ||
Inventory | $10.13M | $8.150M | $8.150M |
Prepaid Expenses | |||
Receivables | $2.702M | $2.516M | $2.516M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $82.86M | $98.86M | $98.86M |
YoY Change | 67.86% | 67.86% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $2.177M | $2.366M | $5.112M |
YoY Change | -24.96% | -20.88% | |
Goodwill | $8.454M | $8.454M | |
YoY Change | 0.0% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $118.0K | $118.0K | $118.0K |
YoY Change | -4.07% | -4.07% | |
Total Long-Term Assets | $16.02M | $16.64M | $16.64M |
YoY Change | -3.51% | -3.51% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $82.86M | $98.86M | $98.86M |
Total Long-Term Assets | $16.02M | $16.64M | $16.64M |
Total Assets | $98.88M | $115.5M | $115.5M |
YoY Change | 51.69% | 51.69% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.235M | $3.061M | $3.061M |
YoY Change | 58.6% | 58.6% | |
Accrued Expenses | $4.416M | $4.758M | $9.109M |
YoY Change | 46.54% | 17.34% | |
Deferred Revenue | $747.0K | $771.0K | |
YoY Change | -8.0% | ||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Long-Term Debt Due | $55.00K | ||
YoY Change | |||
Total Short-Term Liabilities | $12.09M | $14.65M | $14.65M |
YoY Change | -64.09% | -64.09% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $26.62M | $26.50M | $26.57M |
YoY Change | |||
Other Long-Term Liabilities | $517.0K | $558.0K | $2.218M |
YoY Change | -28.09% | -71.88% | |
Total Long-Term Liabilities | $27.14M | $27.05M | $28.78M |
YoY Change | 3386.34% | 264.86% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $12.09M | $14.65M | $14.65M |
Total Long-Term Liabilities | $27.14M | $27.05M | $28.78M |
Total Liabilities | $40.70M | $43.44M | $43.44M |
YoY Change | -10.79% | -10.79% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$327.6M | -$312.0M | |
YoY Change | 18.4% | ||
Common Stock | $385.8M | $384.2M | |
YoY Change | 3858.35% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $51.00K | $51.00K | |
YoY Change | 0.0% | ||
Treasury Stock Shares | |||
Shareholders Equity | $58.18M | $72.06M | $72.06M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $98.88M | $115.5M | $115.5M |
YoY Change | 51.69% | 51.69% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$15.52M | -$13.71M | -$48.50M |
YoY Change | 42.33% | -70.62% | 3.93% |
Depreciation, Depletion And Amortization | $246.0K | $483.0K | $1.426M |
YoY Change | -39.11% | -71.64% | -31.41% |
Cash From Operating Activities | -$31.50M | -$14.72M | -$48.60M |
YoY Change | 141.07% | -2.38% | 26.09% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $56.00K | -$191.0K | $638.0K |
YoY Change | -24.32% | -65.71% | -30.35% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$56.00K | -$191.0K | -$1.973M |
YoY Change | -24.32% | -65.71% | 115.39% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $84.39M | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -486.0K | 85.81M | 83.50M |
YoY Change | -24.65% | -1716280.0% | -8594.1% |
NET CHANGE | |||
Cash From Operating Activities | -31.50M | -14.72M | -48.60M |
Cash From Investing Activities | -56.00K | -191.0K | -1.973M |
Cash From Financing Activities | -486.0K | 85.81M | 83.50M |
Net Change In Cash | -18.59M | 70.89M | 32.92M |
YoY Change | 34.83% | -553.11% | -181.4% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$31.50M | -$14.72M | -$48.60M |
Capital Expenditures | $56.00K | -$191.0K | $638.0K |
Free Cash Flow | -$31.56M | -$14.53M | -$49.24M |
YoY Change | 140.13% | 0.05% | 24.78% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2021Q4 | us-gaap |
Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent | |
CY2021 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001407973 | |
CY2021Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.5479 | |
CY2020Q4 | us-gaap |
Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent | |
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021Q4 | us-gaap |
Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent | |
CY2020Q4 | us-gaap |
Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent | |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2021 | dei |
Document Type
DocumentType
|
10-K | |
CY2021 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2021 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-12-31 | |
CY2021 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
CY2021 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2021 | dei |
Entity File Number
EntityFileNumber
|
001-40988 | |
CY2021 | dei |
Entity Registrant Name
EntityRegistrantName
|
Sonendo, Inc. | |
CY2021 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2021 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-5041718 | |
CY2021 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
26061 Merit Circle | |
CY2021 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 102 | |
CY2021 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Laguna Hills | |
CY2021 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2021 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92653 | |
CY2021 | dei |
City Area Code
CityAreaCode
|
949 | |
CY2021 | dei |
Local Phone Number
LocalPhoneNumber
|
766-3636 | |
CY2021 | dei |
Security12b Title
Security12bTitle
|
Common stock, par value $0.001 per share | |
CY2021 | dei |
Trading Symbol
TradingSymbol
|
SONX | |
CY2021 | dei |
Security Exchange Name
SecurityExchangeName
|
NYSE | |
CY2021 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2021 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2021 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2021 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2021 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2021 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2021 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2021 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2021 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
true | |
CY2021 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q1 | dei |
Entity Public Float
EntityPublicFloat
|
120400000 | |
CY2022Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
26395942 | |
CY2020Q4 | us-gaap |
Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
|
388000 | |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
3308000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2956000 | |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3061000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2208000 | |
CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
8454000 | |
CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
8454000 | |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
118000 | |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1930000 | |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
123000 | |
CY2021Q4 | us-gaap |
Assets
Assets
|
115499000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
76141000 | |
CY2020Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1914000 | |
CY2021 | dei |
Auditor Firm
AuditorFirmId
|
42 | |
CY2021 | dei |
Auditor Name
AuditorName
|
Ernst & Young LLP | |
CY2021 | dei |
Auditor Location
AuditorLocation
|
Irvine, California | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
84641000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
51722000 | |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2516000 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1934000 | |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
8150000 | |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
4338000 | |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3552000 | |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
901000 | |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
98859000 | |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
58895000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2366000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3153000 | |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2746000 | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4758000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3247000 | |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3376000 | |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3714000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
975000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
802000 | |
CY2020Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
28352000 | |
CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2482000 | |
CY2020Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2756000 | |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14652000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
40801000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1730000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
2449000 | |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
26496000 | |
CY2020Q4 | sonx |
Forward Obligation Noncurrent
ForwardObligationNoncurrent
|
2750000 | |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
558000 | |
CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
776000 | |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
43436000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
48690000 | |
CY2020Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
|
281342000 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
21643836 | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
26336536 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1247024 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
26289847 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1200335 | |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
26000 | |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2000 | |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
384132000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
9703000 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-312044000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-263545000 | |
CY2021Q4 | us-gaap |
Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
|
72114000 | |
CY2020Q4 | us-gaap |
Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
|
-253840000 | |
CY2021Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
51000 | |
CY2020Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
51000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
72063000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-253891000 | |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
115499000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
76141000 | |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
33197000 | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
23351000 | |
CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
24861000 | |
CY2020 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
19466000 | |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
8336000 | |
CY2020 | us-gaap |
Gross Profit
GrossProfit
|
3885000 | |
CY2021 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
33913000 | |
CY2020 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
44000 | |
CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1644000 | |
CY2020 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
26695000 | |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18568000 | |
CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
20461000 | |
CY2021 | sonx |
Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
|
261000 | |
CY2020 | sonx |
Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
|
-473000 | |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
52742000 | |
CY2020 | us-gaap |
Operating Expenses
OperatingExpenses
|
46683000 | |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-44406000 | |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-42798000 | |
CY2021 | us-gaap |
Interest Revenue Expense Net
InterestRevenueExpenseNet
|
-4214000 | |
CY2020 | us-gaap |
Interest Revenue Expense Net
InterestRevenueExpenseNet
|
-3961000 | |
CY2021 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-71000 | |
CY2020 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-346000 | |
CY2021 | sonx |
Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
|
52000 | |
CY2020 | sonx |
Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
|
-250000 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-48497000 | |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-46663000 | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2000 | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-48499000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46665000 | |
CY2021 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-8.52 | |
CY2020 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-39.02 | |
CY2021 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
5694594 | |
CY2020 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1195944 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-208914000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46665000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-253891000 | |
CY2021 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
281342000 | |
CY2021 | sonx |
Stock Issued During Period Value Settlement Of Outstanding Forward Obligation Into Common Stock On Initial Public Offering
StockIssuedDuringPeriodValueSettlementOfOutstandingForwardObligationIntoCommonStockOnInitialPublicOffering
|
2698000 | |
CY2021 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
9800000 | |
CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
83792000 | |
CY2021 | sonx |
Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock Warrant Into Common Stock Warrant On Initial Public Offering
AdjustmentsToAdditionalPaidInCapitalReclassificationOfConvertiblePreferredStockWarrantIntoCommonStockWarrantOnInitialPublicOffering
|
3978000 | |
CY2021 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
271000 | |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2372000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-48499000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
72063000 | |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-48499000 | |
CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
-46665000 | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
1426000 | |
CY2020 | us-gaap |
Depreciation
Depreciation
|
2079000 | |
CY2021 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
586000 | |
CY2020 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
531000 | |
CY2021 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
985000 | |
CY2020 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
957000 | |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
558000 | |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
638000 | |
CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
916000 | |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2372000 | |
CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1644000 | |
CY2021 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-71000 | |
CY2020 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-346000 | |
CY2021 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
778000 | |
CY2020 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
807000 | |
CY2021 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-2000 | |
CY2020 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-57000 | |
CY2021 | sonx |
Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
|
52000 | |
CY2020 | sonx |
Change In Fair Value Of Forward Obligation
ChangeInFairValueOfForwardObligation
|
-250000 | |
CY2021 | sonx |
Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
|
261000 | |
CY2020 | sonx |
Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
|
-473000 | |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
582000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-707000 | |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3812000 | |
CY2020 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-2379000 | |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2646000 | |
CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-156000 | |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1128000 | |
CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-369000 | |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-71000 | |
CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-1850000 | |
CY2021 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-72000 | |
CY2020 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
222000 | |
CY2021 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-338000 | |
CY2020 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
1370000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-48605000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-38544000 | |
CY2021 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1335000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1973000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-916000 | |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
84390000 | |
CY2021 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
271000 | |
CY2020 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
44000 | |
CY2021 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
667000 | |
CY2020 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
987000 | |
CY2020 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
5138000 | |
CY2020 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
5138000 | |
CY2021 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
47000 | |
CY2020 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
40000 | |
CY2021 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
450000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
83497000 | |
CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-983000 | |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
32919000 | |
CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-40443000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
51722000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
92165000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
84641000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
51722000 | |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
2000 | |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3445000 | |
CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3446000 | |
CY2021 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
424000 | |
CY2020 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
3082000 | |
CY2021 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
281342000 | |
CY2021 | sonx |
Settlement Of Outstanding Forward Obligation Into Common Stock On Initial Public Offering
SettlementOfOutstandingForwardObligationIntoCommonStockOnInitialPublicOffering
|
2698000 | |
CY2021 | sonx |
Reclassification Of Convertible Preferred Stock Warrant Into Common Stock Warrant On Initial Public Offering
ReclassificationOfConvertiblePreferredStockWarrantIntoCommonStockWarrantOnInitialPublicOffering
|
3978000 | |
CY2021 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
On October 20, 2021, the Company’s Board of Directors approved an amendment to the Company’s certificate of incorporation to effect a reverse split of shares of the Company’s common stock and convertible preferred stock on a 1-for-1.825 basis (the “Reverse Stock Split”). The par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split. | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
84600000 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-312000000.0 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-48500000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-48600000 | |
CY2021 | sonx |
Number Of Operating And Reportable Segments
NumberOfOperatingAndReportableSegments
|
2 | |
CY2021 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates, judgements and assumptions that affect the reported amounts in the consolidated financial statements and disclosures in the accompanying notes, including estimates of probable losses and expenses, as of the date of the accompanying consolidated financial statements. Management considers many factors in selecting appropriate financial accounting policies and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including the expected business and operational changes, the sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Actual results could differ materially from the estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions or conditions.</span></p> | |
CY2021 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Concentration of Risks</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash, cash equivalents and accounts receivable. The Company has established guidelines to mitigate such potential risks by maintaining the Company’s cash balances with entities that management believes possess high credit quality to limit the amount of credit exposure. Substantially all of the Company’s cash and cash equivalents are maintained at one financial institution domiciled in the United States. Cash and cash equivalents can exceed amounts insured by the Federal Deposit Insurance Corporation of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">250,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company has not experienced any losses in its accounts and management believes it is not exposed to any significant credit risk on cash and cash equivalents. The primary objectives of the Company’s investment portfolio are the preservation of capital and maintenance of liquidity.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company believes any concentration of credit risk in its accounts receivable is mitigated by its credit evaluation process, relatively short collection terms and the level of credit worthiness of its customers. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> individual customer accounted for more than 10% of sales or accounts receivable in 2021 or 2020.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company sources materials and services through several vendors. Certain materials are sourced from a single vendor. The loss of certain vendors could result in a temporary disruption of the Company’s commercialization efforts.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company’s products require clearance from the FDA and foreign regulatory agencies before commercial sales can commence. There can be no assurance that the Company’s products in development will receive any of these required clearances. The denial or delay of such clearances may have a material adverse impact on the Company’s business in the future. In addition, after the clearance by the FDA, there is still an ongoing risk of adverse events that did not appear during the device clearance process.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is subject to risks common to companies in the medical device industry, including, but not limited to, new technological innovations, clinical development risk, establishment of appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of its products, product liability and the need to obtain additional financing.</span></p> | |
CY2021 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
CY2020 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
CY2021 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
CY2021 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | |
CY2021 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | |
CY2021 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | |
CY2021Q4 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | |
CY2021Q4 | us-gaap |
Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
|
0 | |
CY2021Q4 | us-gaap |
Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
|
0 | |
CY2021Q4 | us-gaap |
Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
|
0 | |
CY2021 | us-gaap |
Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
|
true | |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
771000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
843000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
5000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
771000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
838000 | |
CY2021 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
800000 | |
CY2020 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
600000 | |
CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
33197000 | |
CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
23351000 | |
CY2021 | us-gaap |
Advertising Expense
AdvertisingExpense
|
300000 | |
CY2020 | us-gaap |
Advertising Expense
AdvertisingExpense
|
300000 | |
CY2020Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1584000 | |
CY2019Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
3447000 | |
CY2021 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
1515000 | |
CY2020 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
996000 | |
CY2021 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
1479000 | |
CY2020 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
2859000 | |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1620000 | |
CY2020Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1584000 | |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
1132000 | |
CY2020Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
1202000 | |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
|
488000 | |
CY2020Q4 | us-gaap |
Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
|
382000 | |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1620000 | |
CY2020Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1584000 | |
CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
776000 | |
CY2020Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
308000 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2021 | sonx |
Minimum Amount Tax Benefits Likely Of Being Realized Upon Settlement
MinimumAmountTaxBenefitsLikelyOfBeingRealizedUponSettlement
|
more than 50% | |
CY2021Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
4911000 | |
CY2020Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
2114000 | |
CY2021Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
270000 | |
CY2021Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
2969000 | |
CY2020Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1916000 | |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
8150000 | |
CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
4338000 | |
CY2021Q4 | sonx |
Inventory Reserves For Excess And Obsolete
InventoryReservesForExcessAndObsolete
|
700000 | |
CY2020Q4 | sonx |
Inventory Reserves For Excess And Obsolete
InventoryReservesForExcessAndObsolete
|
1100000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
3380000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1172000 | |
CY2020Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2208000 | |
CY2021 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
CY2020 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
676000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2956000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
11959000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
11434000 | |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
9593000 | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
8281000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2366000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3153000 | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
1400000 | |
CY2020 | us-gaap |
Depreciation
Depreciation
|
2100000 | |
CY2021 | sonx |
Finite Lived Intangible Asset Weighted Average Amortization Period
FiniteLivedIntangibleAssetWeightedAverageAmortizationPeriod
|
P7Y7M6D | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
4715000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1759000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2956000 | |
CY2020 | sonx |
Finite Lived Intangible Asset Weighted Average Amortization Period
FiniteLivedIntangibleAssetWeightedAverageAmortizationPeriod
|
P6Y8M12D | |
CY2021 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
600000 | |
CY2020 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
500000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
664000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
618000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
442000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
386000 | |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
170000 | |
CY2020Q4 | sonx |
Vendor Invoices Current
VendorInvoicesCurrent
|
2232000 | |
CY2021 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1979000 | |
CY2021 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | |
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1015000 | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4758000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3247000 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2020 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2020 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | |
CY2020Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
17528207 | |
CY2020Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
17031887 | |
CY2021Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
331503 | |
CY2020Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
17031887 | |
CY2021Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
331503 | |
CY2021Q4 | sonx |
Vendor Invoices Current
VendorInvoicesCurrent
|
2779000 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
55000 | |
CY2020Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
47000 | |
CY2021Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
524000 | |
CY2020Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
667000 | |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
1132000 | |
CY2020Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
1202000 | |
CY2021Q4 | us-gaap |
Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
|
771000 | |
CY2020Q4 | us-gaap |
Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
|
840000 | |
CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2482000 | |
CY2020Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2756000 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
70000 | |
CY2020Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
125000 | |
CY2020Q4 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
263000 | |
CY2021Q4 | us-gaap |
Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
|
488000 | |
CY2020Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
180819 | |
CY2020Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
|
281342000 | |
CY2020Q4 | sonx |
Temporary Equity Number Of Common Stock Equivalent Shares
TemporaryEquityNumberOfCommonStockEquivalentShares
|
17031887 | |
CY2020Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1914000 | |
CY2020Q4 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
282198000 | |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2372000 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1644000 | |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2372000 | |
CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1644000 | |
CY2021Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
12247000 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
8.34 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.57 | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
2000000.0 | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1300000 | |
CY2021 | us-gaap |
Lessee Operating Lease Description
LesseeOperatingLeaseDescription
|
The Company leases office space under operating leases with expirations ranging from April 2022 to March 2025, some of which include rent escalations or an option to extend the lease for up to three years per renewal. | |
CY2021 | us-gaap |
Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
|
true | |
CY2021Q4 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P3Y | |
CY2021 | us-gaap |
Lessee Operating Lease Lease Not Yet Commenced Description
LesseeOperatingLeaseLeaseNotYetCommencedDescription
|
the Company has not entered into any leases that have not yet commenced that would entitle the Company to significant rights or create additional obligations. | |
CY2021 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1204000 | |
CY2020 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1122000 | |
CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
1225000 | |
CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
1038000 | |
CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
618000 | |
CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
104000 | |
CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
2985000 | |
CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
280000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2705000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
975000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1730000 | |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y8M15D | |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0761 | |
CY2020 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
197000 | |
CY2021 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
99000 | |
CY2020 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
94000 | |
CY2021 | us-gaap |
Lease Cost
LeaseCost
|
1303000 | |
CY2020 | us-gaap |
Lease Cost
LeaseCost
|
1413000 | |
CY2021 | us-gaap |
Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
|
1206000 | |
CY2020 | us-gaap |
Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
|
1116000 | |
CY2021 | us-gaap |
Lease Cost
LeaseCost
|
1303000 | |
CY2020 | us-gaap |
Lease Cost
LeaseCost
|
1413000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
70731000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
60260000 | |
CY2021Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
30000000 | |
CY2021Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
30000000 | |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2000 | |
CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2000 | |
CY2021 | us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
2000 | |
CY2020 | us-gaap |
Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
|
2000 | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2000 | |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2000 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0331 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0301 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.0113 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.0144 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.2551 | |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.2665 | |
CY2021 | sonx |
Effective Income Tax Rate Reconciliation Stock Based Compensation Percent
EffectiveIncomeTaxRateReconciliationStockBasedCompensationPercent
|
-0.0020 | |
CY2020 | sonx |
Effective Income Tax Rate Reconciliation Stock Based Compensation Percent
EffectiveIncomeTaxRateReconciliationStockBasedCompensationPercent
|
-0.0022 | |
CY2021 | sonx |
Effective Income Tax Rate Reconciliation Other Deferred Adjustments Percent
EffectiveIncomeTaxRateReconciliationOtherDeferredAdjustmentsPercent
|
0.0056 | |
CY2020 | sonx |
Effective Income Tax Rate Reconciliation Other Deferred Adjustments Percent
EffectiveIncomeTaxRateReconciliationOtherDeferredAdjustmentsPercent
|
0.0151 | |
CY2021 | sonx |
Effective Income Tax Rate Reconciliation Perm Items
EffectiveIncomeTaxRateReconciliationPermItems
|
-0.0029 | |
CY2020 | sonx |
Effective Income Tax Rate Reconciliation Perm Items
EffectiveIncomeTaxRateReconciliationPermItems
|
-0.0009 | |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
CY2021Q4 | sonx |
Deferred Tax Assets Fixed Assets And Intangible Assets
DeferredTaxAssetsFixedAssetsAndIntangibleAssets
|
1449000 | |
CY2020Q4 | sonx |
Deferred Tax Assets Fixed Assets And Intangible Assets
DeferredTaxAssetsFixedAssetsAndIntangibleAssets
|
1507000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
80538000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
|
1349000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
864000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
410000 | |
CY2021Q4 | sonx |
Deferred Tax Assets Tax Credits
DeferredTaxAssetsTaxCredits
|
4763000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
68549000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
79476000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
64211000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
1062000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
4338000 | |
CY2021Q4 | sonx |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
660000 | |
CY2020Q4 | sonx |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
783000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
|
1178000 | |
CY2020Q4 | sonx |
Deferred Tax Assets Tax Credits
DeferredTaxAssetsTaxCredits
|
4191000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
|
3000 | |
CY2021Q4 | sonx |
Deferred Tax Liabilities Fixed Assets And Intangible Assets
DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets
|
392000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
|
670000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
890000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
49000 | |
CY2020Q4 | sonx |
Deferred Tax Liabilities Fixed Assets And Intangible Assets
DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets
|
605000 | |
CY2020Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
4338000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
79500000 | |
CY2020Q4 | us-gaap |
Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
|
773000 | |
CY2020Q4 | sonx |
Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
|
2960000 | |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
1062000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
287600000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
245400000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
173400000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
145000000.0 | |
CY2021Q4 | sonx |
Deferred Tax Assets Operating Loss Carryforwards Will Not Expired
DeferredTaxAssetsOperatingLossCarryforwardsWillNotExpired
|
170500000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
|
3300000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
|
2900000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
3900000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
3400000 | |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1800000 | |
CY2021 | us-gaap |
Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
|
0 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1575000 | |
CY2019Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1311000 | |
CY2021 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
204000 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
251000 | |
CY2021 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
12000 | |
CY2020 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
13000 | |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1791000 | |
CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1575000 | |
CY2021 | us-gaap |
Revenues
Revenues
|
33197000 | |
CY2020 | us-gaap |
Revenues
Revenues
|
23351000 | |
CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
24861000 | |
CY2020 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
19466000 | |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
8336000 | |
CY2020 | us-gaap |
Gross Profit
GrossProfit
|
3885000 | |
CY2021 | sonx |
Gross Margin Percentage
GrossMarginPercentage
|
0.25 | |
CY2020 | sonx |
Gross Margin Percentage
GrossMarginPercentage
|
0.17 | |
CY2021 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
33913000 | |
CY2020 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
26695000 | |
CY2020 | sonx |
Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
|
-473000 | |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
52742000 | |
CY2020 | us-gaap |
Operating Expenses
OperatingExpenses
|
46683000 | |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-44406000 | |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18568000 | |
CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
20461000 | |
CY2021 | sonx |
Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
|
261000 | |
CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-42798000 | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
1426000 | |
CY2020 | us-gaap |
Depreciation
Depreciation
|
2079000 | |
CY2021Q4 | us-gaap |
Assets
Assets
|
115499000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
76141000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-48499000 | |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-46665000 | |
CY2021 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
5694594 | |
CY2020 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1195944 | |
CY2021 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-8.52 | |
CY2020 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-39.02 | |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3789645 | |
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
19684684 |